タラポルフィン
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/05/10 21:24:09」(JST)
[Wiki en表示]
Talaporfin
|
Systematic (IUPAC) name |
N-{[(2S,3S)-7-carboxy-3-(2-carboxyethyl)-12-ethyl-2,8,13,18-tetramethyl-17-vinyl-2,3-dihydroporphyrin-5-yl]acetyl}-L-aspartic acid |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Pregnancy cat. |
? |
Legal status |
℞ Prescription only |
Routes |
IV |
Identifiers |
CAS number |
110230-98-3
220201-34-3 (sodium salt) |
ATC code |
None |
PubChem |
CID 5486799 |
UNII |
P4ROX5ELT2 Y |
Chemical data |
Formula |
C38H41N5O9 |
Mol. mass |
711.76 g/mol |
SMILES |
eMolecules & PubChem |
Y (what is this?) (verify)
|
Talaporfin (INN, also known as aspartyl chlorin, mono-L-aspartyl chlorine e6, NPe6, or LS11) is a photosensitizer used in photodynamic therapy (PDT).
It absorbs red light at 664nm normally provided by a laser tuned to this wavelength.[1]
It was approved in Japan (in 2004) for PDT of lung cancer and marketed as Laserphyrin.[2]
It is trademarked as Aptocine by Light Sciences Oncology.[3]
References
- ^ http://journals.lww.com/jto/Fulltext/2006/06000/Photodynamic_Therapy__PDT__for_Lung_Cancers.18.aspx "Photodynamic Therapy (PDT) for Lung Cancers" 2006
- ^ http://meeting.ascopubs.org/cgi/content/abstract/24/18_suppl/7229 "Photodynamic therapy using Laserphyrin for centrally located early stage lung cancer" 2006
- ^ http://www.lsoncology.com/aptocine
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
|
|
SPs/MIs
(M phase) |
Block microtubule assembly
|
- Vinca alkaloids (Vinblastine
- Vincristine
- Vinflunine
- Vindesine
- Vinorelbine)
|
|
Block microtubule disassembly
|
- Taxanes (Cabazitaxel
- Docetaxel
- Larotaxel
- Ortataxel
- Paclitaxel
- Tesetaxel)
- Epothilones (Ixabepilone)
|
|
|
DNA replication
inhibitor |
DNA precursors/
antimetabolites
(S phase)
|
Folic acid
|
- Dihydrofolate reductase inhibitor (Aminopterin
- Methotrexate
- Pemetrexed
- Pralatrexate)
- Thymidylate synthase inhibitor (Raltitrexed
- Pemetrexed)
|
|
Purine
|
- Adenosine deaminase inhibitor (Pentostatin)
- Halogenated/ribonucleotide reductase inhibitors (Cladribine
- Clofarabine
- Fludarabine)
- Thiopurine (Thioguanine
- Mercaptopurine)
|
|
Pyrimidine
|
- Thymidylate synthase inhibitor (Fluorouracil
- Capecitabine
- Tegafur
- Carmofur
- Floxuridine)
- DNA polymerase inhibitor (Cytarabine)
- Ribonucleotide reductase inhibitor (Gemcitabine)
- Hypomethylating agent (Azacitidine
- Decitabine)
|
|
Deoxyribonucleotide
|
- Ribonucleotide reductase inhibitor (Hydroxycarbamide)
|
|
|
Topoisomerase inhibitors
(S phase)
|
I
|
- Camptotheca (Camptothecin
- Topotecan
- Irinotecan
- Rubitecan
- Belotecan)
|
|
II
|
- Podophyllum (Etoposide
- Teniposide)
|
|
II+Intercalation
|
- Anthracyclines (Aclarubicin
- Daunorubicin
- Doxorubicin
- Epirubicin
- Idarubicin
- Amrubicin
- Pirarubicin
- Valrubicin
- Zorubicin)
- Anthracenediones (Mitoxantrone
- Pixantrone)
|
|
|
Crosslinking of DNA
(CCNS)
|
Alkylating
|
- Nitrogen mustards: Mechlorethamine
- Cyclophosphamide (Ifosfamide
- Trofosfamide)
- Chlorambucil (Melphalan
- Prednimustine)
- Bendamustine
- Uramustine
- Estramustine
- Nitrosoureas: Carmustine
- Lomustine (Semustine)
- Fotemustine
- Nimustine
- Ranimustine
- Streptozocin
- Alkyl sulfonates: Busulfan (Mannosulfan
- Treosulfan)
- Aziridines: Carboquone
- ThioTEPA
- Triaziquone
- Triethylenemelamine
|
|
Alkylating-like
|
- Platinum (Carboplatin
- Cisplatin
- Nedaplatin
- Oxaliplatin
- Triplatin tetranitrate
- Satraplatin)
|
|
Nonclassical
|
- Hydrazines (Procarbazine)
- Triazenes (Dacarbazine
- Temozolomide)
- Altretamine
- Mitobronitol
|
|
Intercalation
|
- Streptomyces (Actinomycin
- Bleomycin
- Mitomycin
- Plicamycin)
|
|
|
|
Photosensitizers/PDT |
- Aminolevulinic acid / Methyl aminolevulinate
- Efaproxiral
- Porphyrin derivatives (Porfimer sodium
- Talaporfin
- Temoporfin
- Verteporfin)
|
|
Other |
Enzyme inhibitors
|
- FI (Tipifarnib)
- CDK inhibitors (Alvocidib
- Seliciclib)
- PrI (Bortezomib)
- PhI (Anagrelide)
- IMPDI (Tiazofurine)
- LI (Masoprocol)
- PARP inhibitor (Olaparib)
- HDAC (Panobinostat
- Vorinostat
- Romidepsin)
|
|
Receptor antagonists
|
- ERA (Atrasentan)
- Retinoid X receptor (Bexarotene)
- Sex steroid (Testolactone)
|
|
Other/ungrouped
|
- Amsacrine
- Trabectedin
- Retinoids (Alitretinoin
- Tretinoin)
- Arsenic trioxide
- Asparagine depleters (Asparaginase/Pegaspargase)
- Celecoxib
- Demecolcine
- Elesclomol
- Elsamitrucin
- Etoglucid
- Lonidamine
- HAMLET (human alpha-lactalbumin made lethal to tumor cells)
- Lucanthone
- Mitoguazone
- Mitotane
- Oblimersen
- Omacetaxine mepesuccinate
- mTOR inhibitors (Everolimus
- Temsirolimus)
|
|
|
|
|
English Journal
- Surface layer-preserving photodynamic therapy (SPPDT) in a subcutaneous mouse model of lung cancer.
- Kawakubo M, Eguchi K, Arai T, Kobayashi K, Hamblin MR.SourceDepartment of Thoracic Surgery, School of Medicine, Keio University, Tokyo, Japan. masayoshikaw@aol.com.
- Lasers in surgery and medicine.Lasers Surg Med.2012 Jun 29. doi: 10.1002/lsm.22046. [Epub ahead of print]
- BACKGROUND AND OBJECTIVES: Photodynamic therapy (PDT) may be a less invasive treatment for lung cancer. Our newly developed surface layer-preserving PDT (SPPDT) technique enables us to irradiate deep tumor while preserving the overlying tissue. The aim of this basic study was to verify that the SPPD
- PMID 22752880
- Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas.
- Akimoto J, Haraoka J, Aizawa K.SourceDepartment of Neurosurgery, Tokyo Medical University, Japan. jakimoto@tokyo-med.ac.jp
- Photodiagnosis and photodynamic therapy.Photodiagnosis Photodyn Ther.2012 Jun;9(2):91-9. Epub 2012 Feb 28.
- OBJECTIVES: To investigate the safety and efficacy of photodynamic therapy (PDT) using talaporfin sodium in patients with surgically, completely unresectable malignant gliomas with invasion into the eloquent areas of the brain associated with language and motor functions.MATERIALS AND METHODS: Subje
- PMID 22594978
Japanese Journal
- 光感受性物質 Talaporfin の細胞への取り込みと光化学反応の画像解析
- OP-011-2 胃癌腹膜播種にたいするtalaporfinを用いた光線力学治療(PDT)の基礎的検討(胃癌-2,一般口演,第110回日本外科学会定期学術集会)
- 岸 健太郎,矢野 雅彦,井上 正宏,宮代 勲,本告 正明,田中 晃司,真貝 竜史,後藤 邦仁,高橋 秀典,能浦 真吾,山田 晃正,大植 雅之,大東 弘明,石川 治
- 日本外科学会雑誌 111(臨時増刊号_2), 314, 2010-03-05
- NAID 110007715890
- 酒井 真理,櫛引 俊宏,粟津 邦男
- 日本レーザー医学会誌 = The Journal of Japan Society for Laser Medicine 30(4), 405-414, 2010-01-30
- NAID 10026089063
Related Links
- Talaporfin (INN, also known as aspartyl chlorin, mono-L-aspartyl chlorine e6, NPe6, or LS11) is a photosensitizer used in photodynamic therapy (PDT). It absorbs red light at 664nm normally provided by a laser tuned to this wavelength.
- 光感受性物質のtalaporfinは臨床の場で使用されているのでしょうか? タイトルの通り です。 また、臨床試験の論文等 ... 専門家でもなんでもないので検索した結果だけ お知らせしますと、talaporfin はレザフィリンという名前で医薬品として販売 ...
Related Pictures
★リンクテーブル★
[★]
- 英
- talaporfin
- 化
- タラポルフィンナトリウム talaporfin sodium
- 商
- レザフィリン
[★]
タラポルフィン。タラポルフィンナトリウム